肠癌一二线—培训课件.pptVIP

* * - Baseline treatment characteristics, in terms of the type and number of prior lines of therapy, were well balanced between the two treatment arms. - Nearly 80% of the patients who underwent randomization had received two or more lines of prior treatment for cancer. - All the patients had received prior irinotecan therapy. - In addition, 206 (62.6%) patients had received prior oxaliplatin therapy. 1. Cunningham D, Humblet Y, Siena S, et al. N Engl J Med 2004;351:337-345 * - A third subgroup analysis showed that the number of previous treatment regimens did not affect the efficacy of the ER